(Bruce Rauner's firm) Deerfield drug company sued over heart treatment for premature babies
FTC accuses Ovation Pharmaceuticals of price gouging and antitrust violations
December 17, 2008|By Bruce Japsen, TRIBUNE REPORTER
A Deerfield-based pharmaceutical company gained control of the only two drugs that treat premature babies' heart defects, then raised the cost of treatment nearly 1,300 percent, the Federal Trade Commission said Tuesday in a lawsuit that accused Ovation Pharmaceuticals Inc. of violating antitrust laws. The FTC said Ovation engineered an unlawful acquisition when it acquired the drug NeoProfen in January 2006 from Abbott Laboratories, knowing it was buying the only rival to a drug it bought just one year earlier. Ovation already held the rights to Indocin I.V., a drug developed by Merck & Co.
http://articles.chicagotribune.com/2008-12-17/news/0812160546_1_ovation-pharmaceuticals-premature-babies-premature-infants
------------
his name is not mentioned in the article, of course, but my fb source tells me this is rauner's firm. dont have time to chase that down this minute. maybe someone can confirm or deny.
= new reply since forum marked as read
